Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Zealthy Expands Services to Include Mental and Sexual Health Care
Tech & Innovation Zealthy Expands Services to Include Mental and Sexual Health Care

Zealthy, a prominent telehealth platform, has taken significant strides in expanding its services beyond traditional weight loss solutions, now offering comprehensive mental health support and sexual health treatments. This expansion positions the company as an innovator in the field of accessible

PD-1 Deficiency Impairs B Cell Function in Checkpoint Inhibitor Therapy
Research & Development PD-1 Deficiency Impairs B Cell Function in Checkpoint Inhibitor Therapy

Checkpoint inhibitor therapies have revolutionized cancer treatment by enhancing the immune system's ability to target and destroy cancer cells. By boosting the immune response, these therapies have made significant strides in prolonging the lives of patients with various types of cancer.

Revolutionary Technology Transforms Colon Cancer Cells to Normal State
Research & Development Revolutionary Technology Transforms Colon Cancer Cells to Normal State

In an unprecedented advancement in cancer treatment, a research team led by Professor Kwang-Hyun Cho from KAIST has developed a groundbreaking technology that targets colon cancer by transforming malignant cells into normal-like cells without killing them. Unlike traditional cancer therapies that

Can CAR T-Cell Therapy Revolutionize Multiple Myeloma Treatment?
Research & Development Can CAR T-Cell Therapy Revolutionize Multiple Myeloma Treatment?

Multiple myeloma (MM), a complex form of blood cancer originating in plasma cells, relentlessly impairs blood counts and immune functions. Despite breakthroughs in treatment modalities, MM largely remains incurable, with patients often enduring cycles of remission interrupted by relapses. This

Is Research on Mirror Bacteria Too Risky for Earth's Ecosystems?
Biotech & Bioprocessing Is Research on Mirror Bacteria Too Risky for Earth's Ecosystems?

Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and

Can Annona Squamosa Leaves Revolutionize Pain and Arthritis Treatment?
Research & Development Can Annona Squamosa Leaves Revolutionize Pain and Arthritis Treatment?

Imagine a world where a simple leaf extract from an ancient tree could offer a safer and more effective treatment for pain and arthritis, potentially revolutionizing how we manage these chronic conditions. This scenario is not far-fetched, thanks to groundbreaking research on the medicinal

Breakthrough in ASD Research Reveals Key X Chromosome Genetic Links
Research & Development Breakthrough in ASD Research Reveals Key X Chromosome Genetic Links

A significant breakthrough in the understanding of autism spectrum disorder (ASD) has recently emerged, shedding light on the genetic factors linked to this complex condition and its male predominance. Conducted by researchers from The Hospital for Sick Children (SickKids) in Canada and the

Brain Study Reveals Dual Processing of Touch and Hearing
Research & Development Brain Study Reveals Dual Processing of Touch and Hearing

The human brain's ability to process sensory information is a marvel of biological engineering. Recent research from Harvard Medical School has uncovered new insights into how the brain processes touch and hearing simultaneously, revealing a complex interplay between these senses that enhances

Cognitive Shortcomings of AI Chatbots in Dementia Screening Tests
Tech & Innovation Cognitive Shortcomings of AI Chatbots in Dementia Screening Tests

Recent research has delved into the cognitive limitations of large language models (LLMs), or "chatbots," when subjected to dementia screening tests traditionally used on humans. The study, published in the Christmas issue of The BMJ, reveals that almost all leading LLMs exhibit signs of

Can Russia's New mRNA Vaccine Revolutionize Cancer Treatment by 2025?
Research & Development Can Russia's New mRNA Vaccine Revolutionize Cancer Treatment by 2025?

The recent announcement by Russia regarding the development of a groundbreaking mRNA cancer vaccine represents a significant milestone in the global fight against cancer. Scheduled for free distribution in early 2025, this innovative vaccine has captured worldwide attention due to its potential to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later